Blood test may pinpoint cause of stunted fetal growth

NCT ID NCT05151289

First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time

Summary

This study is testing whether a simple blood test can help doctors tell apart two main causes of intrauterine growth restriction (IUGR) — a condition where a baby grows slower than expected in the womb. The test measures the ratio of two proteins, sFlt-1 and PlGF, which are linked to blood vessel problems in the placenta. Researchers will compare the test results with placental tissue analysis after birth to see if the test can accurately identify vascular causes. The study involves 167 pregnant women with a diagnosis of IUGR, and the findings could lead to a non-invasive way to guide pregnancy management.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Blood test measuring the sFlt-1/PlGF ratio
What this could lead to
If this blood test works, it could help doctors identify the cause of fetal growth restriction without invasive procedures, leading to better monitoring and care for at-risk pregnancies.
What could go wrong
This is a diagnostic study, not a treatment trial. The test may not be accurate enough to replace current methods, and results may vary across different populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FETAL GROWTH RESTRICTION (FGR) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hôpital Louis Mourier

    Colombes, 92700, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.